LifeMD, Inc. (LFMD) is a Medical - Pharmaceuticals company in the Healthcare sector, currently trading at $3.83. It has a SharesGrow Score of 55/100, indicating a above average investment profile with 3 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of LFMD = $146.01 (+3712.3% from the current price, the stock appears undervalued). Analyst consensus target is LFMD = $9 (+121.9% upside).
Valuation: LFMD trades at a trailing Price-to-Earnings (P/E) of -26.8 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 0.19.
Financials: revenue is $194M, +19.6%/yr average growth. Net income is $7M (loss), growing at +41.6%/yr. Net profit margin is -3.7% (negative). Gross margin is 79.8% (-4.5 pp trend).
Balance sheet: total debt is $6M against $23M equity (Debt-to-Equity (D/E) ratio 0.27, conservative). Current ratio is 1.25 (adequate). Debt-to-assets is 9%. Total assets: $70M.
Analyst outlook: 10 / 10 analysts rate LFMD as buy (100%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 88/100 (Pass), Growth 90/100 (Pass), Past 0/100 (Fail), Health 50/100 (Partial), Moat 49/100 (Partial), Future 100/100 (Pass), Income 10/100 (Fail).
